Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: Ascentage Pharma Group Inc.
The purpose of this study is to assess the efficacy and safety of APG-2575 single agent in patients with relapsed/refractory CLL/SLL.
This description comes directly from the study's public registry record.
Zi Chen, Doctor · +8618117275173 · Zi.Chen@ascentage.com
Min Yu, Doctor · +8615000679101 · Min.Yu@ascentage.com
Always discuss trial participation with your own doctor first.
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Nanfang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Hainan General Hospital | Haikou, Hainan, China | Not Yet Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Recruiting |
| Union Hospital medical college Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| The First Affilated Hospital of Soochow University | Suzhou, Jiangsu, China | Not Yet Recruiting |
| People's hospital of Jiangsu Province | Suzhou, Jiangsu, China | Not Yet Recruiting |
| The First Affilated Hospital of Nanchang University | Nanchang, Jiangxi, China | Not Yet Recruiting |
| Institute of blood transfusion of Chinese Academy of Medical Sciences | Tianjin, Tianjin Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Zhejiang University School of Medicine | Hanzhou, Zhejiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05147467